Although our work revealed a potential oncogenic role for CTR1, we found rare amplification or gain‐of‐function mutations of CTR1 in human tumors via mining the cancer genome atlas (TCGA) datasets, indicating that the expression of CTR1 might be subjected to a transcriptional or post‐translational regulation. The gene discussed is SLC31A1; the disease is cancer.